[Ion generators and bronchial asthma. A double-blind placebo controlled study]

Area of Science:

• Pulmonology
• Environmental Health
• Medical Device Technology

Background:

• Asthma bronchiale is a chronic respiratory condition affecting millions worldwide.
• Environmental factors are known to influence asthma symptoms and exacerbations.
• Air ionization devices are proposed as a potential therapeutic intervention for respiratory conditions.

Purpose of the Study:

• To evaluate the efficacy of environmental air ionization as a therapeutic approach for stable, reversible asthma bronchiale.
• To determine if active air ionization significantly improves asthma control compared to a placebo.

Main Methods:

• A double-blind, placebo-controlled study involving 19 adult patients with stable asthma.
• Patients were randomized to receive either an active air ionization device or an inactive placebo device for four weeks.
• Following the initial treatment period, patients switched to the alternative device for another four weeks.
• Daily measurements included peak expiratory flow rate (PEFR), symptom scores, medication usage, and spirometry.

Main Results:

• No statistically significant differences were observed in daily peak flow measurements between the active ionization period and the placebo period.
• Symptom scores and the use of asthma medication remained comparable across both treatment phases.
• Spirometry results did not show any improvement attributable to the air ionization therapy.

Conclusions:

• Environmental air ionization therapy does not appear to be an effective treatment for patients with bronchial asthma.
• Based on the study's findings, this therapeutic approach is not recommended for managing asthma bronchiale.
• Further research may be warranted to explore other environmental interventions or specific patient subgroups.